cALD could act as a prognostic biomarker; Researchers study C-reactive protein in urological cancers;

> Levels of chitotriosidase could act as a prognostic biomarker for stem cell transplantation in cerebral adrenoleukodystrophy. Abstract

> Tokyo-based researchers review C-reactive protein, which has potential as a prognostic and predictive biomarker for urological cancers? Abstract

> In cancer epigenetics, researchers are using ChIP-seq data to identify gene signatures predicting clinical outcomes. Article

> Network-based consensus signatures can be used in predictive biomarker discovery. Abstract

And Finally... Johns Hopkins researcher wins $50,000 prize to move biomarkers from basic research to commercially-available breast cancer diagnostic. Release

Suggested Articles

The FDA has authorized its first COVID-19 antibody test for use in doctors' offices, urgent care centers and emergency rooms.

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.